Matthew Gorgone
NPI 1326368606 · Pulmonary Disease Physician · Rochester, NY
Enrolled with Medicare as Practitioner - Pulmonary Disease · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1326368606
- Entity type
- Individual
- Primary specialty
- Pulmonary Disease PhysicianAllopathic & Osteopathic Physicians
- Sex
- Male
- Sole proprietor
- No
- License
- OS020082 (PA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
16 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
427 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Critical Care, First 30-74 Minutes99291 | 172 | $200 |
| Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 50 Minutes99233 | 85 | $110 |
| Initial Hospital Care With Moderate Level of Medical Decision Making, If Using Time, at Least 75 Minutes99223 | 34 | $164 |
| Ultrasound of Heart, Follow-Up93308 | 27 | $23 |
| Ultrasound Scan of Chest76604 | 17 | $26 |
| Test to Examine How Well the Lungs Exchange Gases94729 | 17 | $8 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 13 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta | 96 | 21 |
| Fluticasone Propion/Salmeterolbrand: Fluticasone-Salmeterol | 28 | — |
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 24 | — |
| Umeclidinium Brm/Vilanterol Trbrand: Anoro Ellipta | 23 | — |
| Pantoprazole Sodium | 21 | — |
| Azelastine Hcl | 19 | — |
Practice location
Mailing address
Registry dates
- Enumerated
- 2010-06-09
- Last updated
- 2024-09-06
- Certified
- 2024-09-06
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.